Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXAZOMIB vs JAKAFI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IXAZOMIB vs JAKAFI: Safety Overview

Metric IXAZOMIB JAKAFI
Total FAERS Reports 22,324 1,749
Deaths Reported 4,704 152
Death Rate 21.1% 8.7%
Hospitalizations 7,433 214
Average Patient Age 70.3 yrs 70.6 yrs
% Female Patients 47.2% N/A
FDA Approval Date Nov 20, 2015 N/A
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A